ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 176328 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 176328; 2) Community: the network communities that were significantly associated with the response to NSC 176328; 3) Molecule: the relationships between components within communities and NSC 176328; 4) MDR: the compounds that were significantly associated with the NSC 176328.

NSC Compound Enrichment Correlation
NSC 710550 Null 0.024108502230778 0.67175776
NSC 721390 2',3'-dideoxy-2',3'-didehydrothymidyl 5-nitrofurfuryl N-methyl-N-(4-chlorobutyl) phosphoramidate 0.024108502230778 -0.10628728
NSC 728037 2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline 0.024108502230778 0.36789573
NSC 747174 Null 0.024108502230778 0.37077286
NSC 758664 Sirolimus [USAN] 0.024108502230778 -0.10254541
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 0.0241085022307781 0.49212506
NSC 142475 Null 0.0241085022307781 0.14000551
NSC 1433 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE 0.0241085022307781 0.31462141
NSC 681641 Camptothecin Derivative 0.0247979034812107 0.1715712
NSC 716526 2H-1-Benzopyran-3-carboxamide, 6-(chloromethyl)-2-oxo-N-pentyl- 0.0247979034812107 -0.29278857
Total:145  Current:91    [First] [Prev] [Next] [Last]